J&J Says It's Wait And See On COVID-19 Vaccine Delay, Outlines Rosier Outlook for 2021

 
• By Jessica Merrill
  
Canine
J&J and the public are eagerly awaiting more data on a COVID-19 vaccine trial delay • Source: Shutterstock

More from Earnings

More from Business